Regulatory, policy reforms crucial for future of India's pharma R&D: Report

India's regulatory and policy reforms are crucial for the future of pharmaceutical R&D, streamlining approval processes and strengthening IP protections. Despite significant transformation, challenges like inadequate drug regulation capacity and high compliance costs hinder growth. The report suggests promoting India as a hub for pharmaceutical research and development.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sWd74oz
via IFTTT